Key result
Humanin reverses paroxetine-induced sexual dysfunction and restores hormonal balance in male rats.
Why the study?
SSRIs such as paroxetine frequently cause male sexual dysfunction by disrupting neuroendocrine balance and central dopaminergic pathways, prompting investigation into whether humanin could mitigate these impairments.
Does humanin mitigate paroxetine-induced reproductive and behavioral impairments in male Sprague-Dawley rats?
RCT (n=58)
randomized
Does humanin mitigate paroxetine-induced reproductive and behavioral impairments in male Sprague-Dawley rats?
Humanin peptide demonstrates pro-fertility and neuroprotective effects, emerging as a potential therapeutic agent to preserve male reproductive health during SSRI treatment in a preclinical model.
Selective serotonin reuptake inhibitors (SSRIs) such as paroxetine frequently induce male sexual dysfunction by disrupting neuroendocrine balance and central dopaminergic pathways. This study investigated whether humanin, a mitochondria-derived peptide, could mitigate paroxetine-induced reproductive and behavioral impairments in male Sprague-Dawley rats. In Phase 1, fifty rats were randomized into control, sham, paroxetine (20 mg/kg/day via oral gavage), humanin (1 mg/kg/day via subcutaneous infusion), and paroxetine + humanin groups (n = 10/group) to evaluate sexual behavior, sperm quality, serum hormones, and dopaminergic activity within the nucleus accumbens (NAc) and medial preoptic area (MPOA). In Phase 2, central neurochemical dynamics in a separate cohort of healthy rats (n = 8) were assessed using in vivo microdialysis coupled with HPLC-ECD to measure extracellular dopamine and its metabolites in the NAc. Paroxetine significantly impaired sexual motivation and performance, reduced sperm motility, concentration, and mitochondrial membrane potential, elevated prolactin, and suppressed testosterone, luteinizing hormone, and dopamine levels in both the NAc and MPOA (p < 0.05). Humanin co-administration significantly reversed these adverse effects, restoring ejaculatory frequency, copulatory efficiency, sperm parameters, and hormonal balance. Furthermore, humanin counteracted the paroxetine-induced dopaminergic suppression in the MPOA and NAc, while acute microdialysis revealed a supportive upward trend in dopamine turnover under basal conditions. These findings demonstrate that humanin exerts potent pro-fertility and neuroprotective effects against antidepressant-induced sexual dysfunction. By preserving mitochondrial integrity and modulating central dopaminergic and neuroendocrine circuits, humanin emerges as a promising therapeutic agent for preserving male reproductive health during SSRI treatment.
No takes yet. Share an insight, caveat, or question.
Akipek et al. (2026) conducted an RCT in SSRI-induced male sexual dysfunction (n=58). Humanin vs. Control, sham, and paroxetine alone was evaluated on Sexual behavior, sperm quality, serum hormones, and dopaminergic activity. Humanin co-administration significantly reversed paroxetine-induced sexual dysfunction, restoring ejaculatory frequency, sperm parameters, and hormonal balance in male rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: